Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-015963
Filing Date
2023-06-20
Accepted
2023-06-20 16:15:22
Documents
1
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4009
  Complete submission text file 0000899243-23-015963.txt   5371
Mailing Address 215 FIRST STREET, SUITE 440 CAMBRIDGE MA 02142
Business Address
Horobin Joanna (Reporting) CIK: 0001560959 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 231025242

Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

EIN.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)